Revvity Inc (BSP:R1VT34)
R$ 23.77 0 (0%) Market Cap: 81.00 Bil Enterprise Value: 93.46 Bil PE Ratio: 56.19 PB Ratio: 1.79 GF Score: 65/100

Revvity Inc at TD Cowen Health Care Conference Transcript

Mar 04, 2024 / 02:10PM GMT
Release Date Price: R$19.54
Daniel Gregory Brennan
TD Cowen, Research Division - MD and Senior Tools & Diagnostics Analyst

(technical difficulty) So I'm Dan Brennan, (technical difficulty) Prahlad Singh, President and CEO of Revvity. So Prahlad, welcome.

Prahlad R. Singh
Revvity, Inc. - CEO, President & Director

Thank you.

Daniel Gregory Brennan
TD Cowen, Research Division - MD and Senior Tools & Diagnostics Analyst

And thanks for coming. Listen, I will check my e-mail a couple of times throughout if any of you want to pose any questions. I'll see if I can weave those in. We have a list and a little over 30 minutes to tackle it.

Questions & Answers

Daniel Gregory Brennan
TD Cowen, Research Division - MD and Senior Tools & Diagnostics Analyst

So maybe I thought just to kick it off, obviously, the long-term guide. You guys just took it down from 10% to 6% to 8%. You've got 75 to 100 basis points of EBIT expansion. You kind of tweaked that down to 75 basis points, still

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot